Tag - pfizer

 
 

PFIZER

Japan Times
WORLD
Dec 15, 2020
A weapon to ‘win the war’: U.S. hospitals get initial coronavirus shots
The arrival of the Pfizer-BioNTech vaccine offers a glimmer of hope amid a pandemic that has already seen almost 300,000 Americans die.
Japan Times
COMMENTARY / World
Dec 12, 2020
Vaccines alone aren’t enough to beat COVID-19
While an effective vaccine is sure to help, a safe oral antiviral drug would truly step up efforts to fight the pandemic.
Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD
Dec 6, 2020
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Japan Times
WORLD / Science & Health
Dec 4, 2020
Pfizer scaled back COVID-19 vaccine output targets earlier this year
Pfizer Inc. scaled back its COVID-19 production targets earlier this year after the drugmaker ran into difficulties securing all the materials it needs to produce the shots at a large scale.
Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
COMMENTARY / World
Nov 21, 2020
Why Moderna’s vaccine win is a giant leap against pandemics
Alongside recent results from Pfizer, the news that a vaccine is proving effective is a great step forward.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health / FOCUS
Nov 10, 2020
Why Pfizer’s vaccine won't be at the local pharmacy anytime soon
The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.
Japan Times
WORLD / Science & Health
Nov 10, 2020
Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle
The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji